X0202
SCHEDULE 13D/A
0000921895-26-000850
0002042077
XXXXXXXX
LIVE
1
Common Stock, $0.01 par value
04/06/2026
true
0001227636
64131A105
Neuronetics, Inc.
3222 PHOENIXVILLE PIKE
MALVERN
PA
19355
Jorey Chernett
(248) 469-8811
6222 Indianwood Tr.
Bloomfield Hills
MI
48301
0002042077
N
Chernett Jorey
PF
N
X1
9778718.00
0.00
9778718.00
0.00
9778718.00
N
14.12
IN
Common Stock, $0.01 par value
Neuronetics, Inc.
3222 PHOENIXVILLE PIKE
MALVERN
PA
19355
This Amendment No. 1 to Schedule 13D ("Amendment No. 1") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026 (the "Original Schedule 13D") with respect to the Shares. Except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Schedule 13D.
Item 4 is hereby amended to add the following:
On April 6, 2026, the Reporting Person delivered a letter (the "Letter") to the Board of Directors of the Issuer (the "Board") calling for the immediate initiation of a comprehensive review of strategic alternatives, including the potential sale of the Issuer's transcranial magnetic stimulation ("TMS") business. In the Letter, the Reporting Person expressed the view that the Issuer's current structure and strategy are not maximizing shareholder value and that separating or divesting the TMS business should be evaluated as part of a broader strategic review. The Reporting Person also noted that such a transaction could enhance the Issuer's financial flexibility and allow for a more focused strategic direction. The Reporting Person urged the Board to engage qualified investment bankers and immediately commence a formal process to evaluate strategic alternatives. A copy of the Letter is filed as Exhibit 1 to this Amendment No. 1 and is incorporated herein by reference.
Item 7 is hereby amended to add the following:
Exhibit 1: Letter from Jorey Chernett to the Board of Directors of Neuronetics, Inc., dated April 6, 2026.
Chernett Jorey
/s/ Jorey Chernett
Jorey Chernett
04/08/2026